Oxymetazoline hydrochloride combined with mometasone nasal spray for persistent nasal congestion (pilot study).

World Allergy Organ J

From the Department of Medicine, Pulmonary, Allergy and Critical Care Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania; National Allergy, Asthma, and Urticaria Centers of Charleston, Charleston, South Carolina; University of South Florida, Department of Allergy/Immunology, James A. Haley Veterans' Administration Hospital, Tampa, Florida.

Published: March 2011

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651108PMC
http://dx.doi.org/10.1097/WOX.0b013e31820f8faeDOI Listing

Publication Analysis

Top Keywords

oxymetazoline hydrochloride
4
hydrochloride combined
4
combined mometasone
4
mometasone nasal
4
nasal spray
4
spray persistent
4
persistent nasal
4
nasal congestion
4
congestion pilot
4
pilot study
4

Similar Publications

A simple and rapid method based on Raman microsphere immunochromatography was developed in this study for the simultaneous detection of influenza A and B viruses and SARS-CoV-2 on a single test T-line. Three types of Raman microspheres with different Raman characteristics were used as the signal sources and were labelled with monoclonal antibodies against FluA, FluB and SARS-CoV-2, respectively. A mixture of antibodies containing anti-FluA monoclonal antibody, anti-FluB monoclonal antibody and anti-SARS-CoV-2 was sprayed on the detection line (T), and goat polyclonal antibody to chicken (IgY) encapsulated on the quality control line (C), for qualitative detection of these three viruses by the double antibody sandwich method.

View Article and Find Full Text PDF
Article Synopsis
  • Challenging adherence to positive airway pressure (PAP) therapy in patients with allergic rhinitis was highlighted in a case study of a 62-year-old male with obstructive sleep apnea (OSA) who struggled with PAP for ten years.
  • The combination of daily intranasal oxymetazoline and fluticasone significantly improved his tolerance and adherence to PAP therapy, unlike using fluticasone alone.
  • This approach may help enhance CPAP tolerance in patients with OSA and rhinitis, offering a promising area for future exploration to improve treatment adherence.
View Article and Find Full Text PDF

Objective: To evaluate and determine the prevalence of ingredients in over-the-counter (OTC) nasal sprays.

Study Design: Cross-sectional.

Setting: Retail pharmacies.

View Article and Find Full Text PDF

Real-World Large Sample Assessment of Drug-related Dry Eye Risk: Based on the FDA Adverse Event Reporting System Database.

Asia Pac J Ophthalmol (Phila)

October 2024

Xiamen University affiliated Xiamen Eye Center, Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Fujian Engineering and Research Center of Eye Regenerative Medicine, Eye Institute of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian 361005, China; Department of Ophthalmology, the First Affiliated Hospital of University of South China, Hengyang, Hunan 421001, China; Department of Ophthalmology, Xiang'an Hospital of Xiamen University, Xiamen, Fujian 361005, China. Electronic address:

Purpose And Design: This study aimed to evaluate the risk of drug-related dry eye using real-world data, underscoring the significance of tracing pharmacological etiology for distinct clinical types of dry eye.

Methods: Analyzing adverse event reports in the Food and Drug Administration Adverse Event Reporting System (FAERS) from January 2004 to September 2023, we employed disproportionality analysis and the Bayesian confidence propagation neural network algorithm. The analysis involved categorizing drugs causing dry eye, assessing risk levels, and conducting segmental assessments based on the time of onset of drug-related dry eye adverse reactions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!